Characterisation of erusiolin - a new peptide hormone

肥胖和II型糖尿病是澳大利亚的流行病。肠源性激素是这些疾病中的关键介质，因为它们在调节食欲和血糖水平中起作用。这些激素的治疗调节也为患者提供了显著的益处。在这项提案中，我们将确定代谢功能，如食欲控制，为以前未表征的激素，这是一个未探索的治疗目标肥胖和糖尿病。

Obesity and type II diabetes are epidemic diseases in Australia. Gut-derived hormones are key mediators in these diseases, due to their role in regulating appetite and blood glucose levels. Therapeutic modulation of these hormones also provides significant benefits for patients. In this proposal, we will determine the metabolic functions, such as appetite control, for a previously uncharacterised hormone, which is an unexplored therapeutic target for obesity and diabetes.